BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 19733826)

  • 1. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
    Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
    Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness-to-pay for community-based insurance in Burkina Faso.
    Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
    Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations.
    Barner JC; Branvold A
    Res Social Adm Pharm; 2005 Mar; 1(1):77-100. PubMed ID: 17138467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay for inhaled insulin: a contingent valuation approach.
    Sadri H; MacKeigan LD; Leiter LA; Einarson TR
    Pharmacoeconomics; 2005; 23(12):1215-27. PubMed ID: 16336016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
    Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
    Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay for health insurance among rural and poor persons: field evidence from seven micro health insurance units in India.
    Dror DM; Radermacher R; Koren R
    Health Policy; 2007 Jun; 82(1):12-27. PubMed ID: 16971017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of parental willingness to pay and willingness to stay for "painless" intravenous catheter placement.
    Walsh BM; Bartfield JM
    Pediatr Emerg Care; 2006 Nov; 22(11):699-703. PubMed ID: 17110860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter?
    Onwujekwe O; Okereke E; Onoka C; Uzochukwu B; Kirigia J; Petu A
    Health Policy Plan; 2010 Mar; 25(2):155-61. PubMed ID: 20156920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equity shortfalls & failure of the welfare state: community willingness to pay for health care at government facilities in Jehlum (Pakistan).
    Masud TI; Farooq N; Ghaffar A
    J Ayub Med Coll Abbottabad; 2003; 15(4):43-9. PubMed ID: 15067833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
    Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
    J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.
    Baser O; Bouchard J; DeLuzio T; Henk H; Aagren M
    Adv Ther; 2010 Feb; 27(2):94-104. PubMed ID: 20352392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient valuation of pharmacist services for self care with OTC medications.
    Hong SH; Spadaro D; West D; Tak SH
    J Clin Pharm Ther; 2005 Jun; 30(3):193-9. PubMed ID: 15896235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.